Legal HIGH

Delaware

  • Delaware launched adult-use cannabis sales on August 1, 2025 — later than initially projected — via 13 legacy medical dispensaries that paid $100,000 conversion fees, generating only $29.3 million in retail sales over the first seven months, far below the original $281 million annual projection.
  • A fierce political standoff between Governor Matt Meyer and the legislature over Senate Bill 75 — which would cap local buffer zones at 500 feet — has locked out the majority of the 79 newly licensed conditional retailers, particularly in Sussex County where a three-mile buffer requirement creates a near-total ban.
  • Delaware enacted the Clean Slate Act (SB 111 and SB 112) in 2021, automating expungement for over 290,000 eligible Delawareans starting August 2024, addressing a history where Black residents were 4.2 times more likely to be arrested for cannabis possession than white residents.
  • The state's social equity framework reserves 47 of 125 statutory licenses for disproportionately impacted applicants, with a $1,000 application fee (versus the standard rate), a 40% discount on biennial licensing fees, and the Social Equity Financial Assistance (SEFA) grant program funded by medical conversion fees.
  • Delaware's proximity to Pennsylvania — a medical-only state with nearly 9 million potential cannabis consumers — positions northern New Castle County dispensaries as a significant cross-border revenue opportunity once zoning disputes are resolved.
Delaware represents a unique case study in the evolution of East Coast cannabis policy. The state officially transitioned into a fully operational adult-use cannabis market on August 1, 2025, when 13 converted medical dispensaries opened their doors to recreational consumers. This milestone was achieved through a protracted and politically contentious legislative process, marked by the General Assembly overriding former Governor John Carney's veto in 2023 to pass House Bills 1 and 2. While the statutory framework is now firmly established under the regulatory purview of the Office of the Marijuana Commissioner (OMC), the market's infancy has been characterized by slower-than-anticipated revenue growth and ongoing jurisdictional battles regarding local zoning authority. The evidence suggests that Delaware's market trajectory is currently constrained by municipal resistance and strict county-level buffering ordinances, particularly in Sussex County. Current Governor Matt Meyer has taken a staunch 'home rule' stance, vetoing state legislation (SB 75) that would have restricted the ability of local governments to zone cannabis retailers out of their jurisdictions. Instead, the Governor has proposed a 4.5% revenue-sharing model to incentivize local participation. This political tug-of-war has created a bottleneck for the 125 newly licensed businesses — including numerous social equity applicants — that are struggling to secure compliant real estate. From a criminal justice perspective, Delaware has made significant strides to correct historical disparities. Research demonstrates that prior to legalization, Black Delawareans were roughly 4.2 times more likely to be arrested for cannabis possession than white residents, despite comparable usage rates. To address these systemic inequities, the state enacted the Clean Slate Act (SB 111 and SB 112), which automated the expungement process for over 290,000 eligible individuals starting in August 2024. As Delaware navigates the complex intersection of market economics, border competition with Maryland and New Jersey, and internal zoning disputes, it remains a critical state to monitor for policy outcomes in legislative legalization models.
Market

Market Data

~$74.2M combined (first 7 months adult-use + 2024 medical)[8] Total Sales Aug 2025 – Mar 2026 (adult-use); 2024 Calendar Year (medical)
N/R Per Capita Rank Partial year — full ranking available after 2026
~$4.4M[8] Tax Revenue
Delaware's adult-use market is overseen by the Office of the Marijuana Commissioner (OMC), within the Department of Safety and Homeland Security. The state anticipated strong early revenues, but initial data indicates a sluggish start primarily driven by supply chain constraints, licensing delays, and restrictive municipal zoning. Delaware's first Marijuana Commissioner, Robert Coupe, initially projected $281 million in annual retail sales. Over the first seven months of operation (August 2025 through early March 2026), the state logged just $29.3 million in retail sales, averaging $4.2 million per month — annualizing to roughly $50 million, less than 20% of the original estimate. This deficit is largely attributed to adult-use sales being confined to the 13 legacy medical dispensaries that paid $100,000 conversion fees. The OMC has issued 79 conditional licenses from its late-2024 lottery, but strict local zoning bans — particularly Sussex County's three-mile buffer requirement — have prevented the vast majority of new retailers from opening. Delaware applies a 15% retail excise tax. Medical cannabis is entirely tax-exempt. The state has decoupled from federal IRC Section 280E for state income tax purposes, providing meaningful financial relief to operators.
Criminal Justice

Criminal Justice

Group Metric Value
Black Disparity Ratio 4.2x more likely to be arrested for cannabis possession than white residents, despite comparable usage rates [23]
Black % of Incarcerated for Drug Offenses 86.8% of those incarcerated for drug offenses, despite being ~20% of general population [24]
White % of Cannabis Arrests (All Criminal Offenses) 56% of all criminal offenses [24]
Delaware's history of cannabis enforcement exhibits profound racial disparities. Prior to legalization, Black Delawareans were 4.2 times more likely to be arrested for cannabis possession than white residents despite comparable usage rates, and comprised 86.8% of those incarcerated for drug offenses while making up only ~20% of the general population. AG Jennings's 2019 directive to cease prosecution of simple possession under 175 grams was a pivotal early reform. The Clean Slate Act (SB 111 and SB 112), passed in 2021 and implemented starting August 2024, automated expungement for over 290,000 eligible Delawareans without requiring a petition or fee. The exact count of records cleared as of Q1 2026 has not been publicly released by the State Bureau of Identification. Cannabis arrests post-legalization are not comprehensively published due to the transition to a civil citation model for simple possession.
Borders

Border Dynamics

Neighbor Legal Status Notes
Pennsylvania Medical Only The lack of adult-use legalization in PA presents a significant opportunity for DE retailers in northern New Castle County to capture cross-border recreational consumers. PA residents near the DE border constitute a large potential customer base.
Maryland Adult-Use Operational MD launched adult-use in 2023 and averages nearly $80M in monthly sales, dwarfing DE's early performance and capturing consumers in southern and western DE. Was a primary competitor drawing DE consumers before August 2025.
New Jersey Adult-Use Operational NJ averages $96.2M in monthly sales. Prior to August 2025, DE regulators estimated the state was losing $1M per month in tax revenue to NJ and MD combined.
Delaware's small geographic footprint makes it highly susceptible to cross-border economic pressures. Prior to the August 2025 adult-use launch, Delaware was surrounded by operational recreational markets in New Jersey and Maryland, resulting in significant capital flight — an estimated $1 million per month in lost tax revenue. Now that Delaware has its own market, the dynamic has partially reversed: northern New Castle County dispensaries are positioned to capture cross-border recreational consumers from Pennsylvania, a medical-only state with a large population base near the Delaware border. Maryland's average of nearly $80M in monthly sales and New Jersey's $96.2M in monthly sales continue to dwarf Delaware's nascent market and remain competitive pressures in the south and north respectively.
Political

Political Landscape

Most Recent Vote
HB 1 and HB 2 passed the General Assembly in April 2023. Both became law without Governor Carney's signature. The State Senate has voted to override Governor Meyer's veto of SB 75 (zoning cap bill), but the House has not yet finalized the override vote as of early 2026.[3]
Active Bills
SB 75 (zoning override — would cap local buffer zones at 500 feet; vetoed by Governor Meyer, Senate override vote taken, House override pending); SB 226 (would permit terminally ill patients to consume non-combustible medical cannabis within hospital facilities, passed Senate unanimously in early 2026)[26]
Delaware's political discourse surrounding cannabis now centers not on legalization itself, but on the mechanics of local implementation. The tension between state-level economic development and municipal-level zoning control defines the 2026 legislative session. Governor Meyer's veto of SB 75 — and his proposed 4.5% revenue-sharing alternative — reflects a genuine philosophical commitment to home rule rather than outright opposition to cannabis expansion. The State Senate's override vote puts pressure on the House, where the final outcome remains uncertain. If Delaware can resolve the zoning bottleneck, its proximity to Pennsylvania's medical-only market of nearly 9 million potential consumers represents a strategic near-term revenue opportunity. SB 226 (hospital use for terminally ill patients) passed the Senate unanimously in early 2026, signaling continued bipartisan support for sensible expansion at the margins.

Sources

  1. ↑ State of Delaware — Delaware Launches Legal Adult-Use Cannabis Sales
  2. ↑ State of Delaware — Delaware to Launch Adult-Use Marijuana on August 1
  3. ↑ MPP — Delaware's Cannabis Legalization Laws
  4. ↑ MPP — Delaware SB 17 Summary
  5. ↑ MPP — Delaware's New Decriminalization Law
  6. ↑ MJBizDaily — Why are Delaware cannabis sales off to such a slow start
  7. ↑ OMC — 2024 Annual Report
  8. ↑ WHYY — Delaware retail weed sales
  9. ↑ Delaware Department of Revenue — Retail Marijuana Tax FAQs
  10. ↑ State of Delaware — OMC Reports Strong First Month of Recreational Cannabis Sales
  11. ↑ Saul Ewing — Delaware Marijuana Licensing Guide
  12. ↑ WHYY — Delaware's new AG says her office won't prosecute possession of small amounts of pot
  13. ↑ State of Delaware — Governor Matt Meyer Vetoes SB 63 and SB 75
  14. ↑ State of Delaware — Governor Matt Meyer
  15. ↑ State of Delaware — Attorney General Kathy Jennings
  16. ↑ Ballotpedia — 2026 Delaware Legislative Session
  17. ↑ U.S. Census Bureau — Delaware Population Data (DataCommons)
  18. ↑ NORML — Delaware Legalization
  19. ↑ State of Delaware — Office of the Marijuana Commissioner Adult Use
  20. ↑ OMC — Frequently Asked Questions
  21. ↑ House Democrats Delaware — House Passes Legislation to Expand the Expungement Process
  22. ↑ ACLU Delaware — Clean Slate Fact Sheet
  23. ↑ ACLU — Marijuana Arrest Report
  24. ↑ Prison Policy Initiative — Race and Incarceration
  25. ↑ Delaware Statistical Analysis Center — Drug Offense 2020 Fact Sheet
  26. ↑ Marijuana Moment — Delaware Senate Passes Bill to Let Terminally Ill Patients Use Medical Marijuana in Hospitals
  27. ↑ Spotlight Delaware — Delaware cannabis market analysis
  28. ↑ National Governors Association — Former Governors
  29. ↑ Delaware Cannabis Policy Coalition
  30. ↑ American Progress — Clean Slate expungement analysis
  31. ↑ WBOC — Delaware cannabis revenue loss to neighboring states